This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gower, B. A. Articles by Kent, E. Search for Related Content PubMed PubMed Citation Articles by Gower, B. A. Articles by Kent, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL ESTRONE

Leptin in Postmenopausal Women: Influence of Hormone Therapy, Insulin, and Fat Distribution¹

University of Alabama at Birmingham, Department of Nutrition Sciences, Division of Physiology and Metabolism, and University of Alabama at Birmingham Obesity Research Center, Birmingham, Alabama 35294-3360

Address correspondence and requests for reprints to: B. A. Gower, University of Alabama at Birmingham, Department of Nutrition Sciences, 441 Webb Building, 1675 University Boulevard, Birmingham, Alabama 35294-3360. E-mail: bgower{at}uab.edu

Whether use of hormone-replacement therapy (HRT) influences menopause-related changes in body weight is unclear. HRT may affect energy balance by influencing synthesis of the adipocyte-derived hormone leptin. The objectives of this study were to: 1) identify factors influencing circulating leptin in postmenopausal women; 2) determine whether HRT influences serum leptin after adjusting for confounding factors; and, 3) identify potential independent effects of HRT or leptin on resting energy expenditure (REE). Subjects were 54 postmenopausal women, 45–55 yr old, 35 of whom used HRT (estrogen plus progestin). Total and regional body composition and fat distribution were determined by dual-energy x-ray absorptiometry and computed tomography; fasting serum leptin and insulin, by RIA; and REE, by indirect calorimetry. Stepwise multiple linear regression analysis indicated that serum leptin could best be predicted from total fat mass, fasting serum insulin, and total lean mass [log leptin = 1.08·log fat mass) + (0.46·log insulin) + (-1.25·log lean mass) + 1.88; model R² = 0.78, P < 0.001]. Multiple linear regression analysis indicated that visceral fat was independently related to leptin (parameter estimate = 0.23, P < 0.05), after adjusting for sc abdominal fat and leg fat, as well as lean mass and insulin. After adjusting for total fat mass, total lean mass, and fasting insulin, serum leptin did not differ between users and nonusers of HRT (21.7 ± 1.0 vs. 20.2 ± 1.3 ng/mL , P = 0.369, adjusted mean ± SE, respectively). Serum estradiol was inversely correlated with (adjusted) leptin in non-HRT users (r = -0.50), suggesting that ovarian senescence may lead to an increase in leptin. Multiple linear regression analysis indicated that REE (adjusted for fat mass, fat-free mass, and ethnicity) was not associated with leptin (P = 0.298) or hormone use status (P = 0.999; 1323 ± 31 vs. 1316 ± 42 kcal/day, adjusted mean ± SE for users and nonusers, respectively). These results indicate that, in postmenopausal women: 1) total fat mass, lean mass, and fasting insulin, but not HRT, are significant determinants of serum leptin; 2) visceral and sc fat contribute to serum leptin; and, 3) neither HRT nor leptin is independently related to REE.

This article has been cited by other articles:

				J. Munoz and B. A. Gower Relationship between Serum Leptin Concentration and Low-Density Muscle in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1157 - 1161. [Abstract] [Full Text] [PDF]

				X. Hu, S. C. Juneja, N. J. Maihle, and M. P. Cleary Leptin--A Growth Factor in Normal and Malignant Breast Cells and for Normal Mammary Gland Development J Natl Cancer Inst, November 20, 2002; 94(22): 1704 - 1711. [Abstract] [Full Text] [PDF]